• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子(EGF)和表皮生长因子受体(EGFR)的表达与胰腺导管癌的转移密切相关。

Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.

作者信息

Pryczynicz Anna, Guzińska-Ustymowicz Katarzyna, Kemona Andrzej, Czyzewska Jolanta

机构信息

Departments of General Pathomorphology, Medical University of Białystok, Białystok, Poland.

出版信息

Anticancer Res. 2008 Mar-Apr;28(2B):1399-404.

PMID:18505086
Abstract

BACKGROUND

The epidermal growth factor family members: EGF, EGFR and the c-erbB-2(HER-2/neu) gene product have been found to play a role in carcinomas of the stomach, liver, breast, ovary and lungs. Recent reports have indicated that they are also involved in the growth of pancreatic ductal carcinoma, its invasiveness and metastasis.

PATIENTS AND METHODS

Thirty-six patients with pancreatic ductal carcinoma were analysed with respect to sex, age, histological type, malignancy grade (G), pTN status (pTN), local lymph node involvement and distant metastasis. The tumor levels of EGF, EGFR and c-erbB-2 expression were determined immunohistochemically.

RESULTS

Expression of c-erbB-2 was observed in 24/36 cases, EGF in 13/36 cases and EGFR in 18/36 cases. Overexpression of EGF and EGFR was associated with metastasis to lymph nodes and other organs. A correlation was also found between EGF expression and the presence of EGFR in the tumour. The expression of c-erbB-2 protein was not found to correlate with any parameters.

CONCLUSION

EGF and EGFR play a key role in neoplastic spread through lymph node involvement and metastasis to other organs.

摘要

背景

已发现表皮生长因子家族成员:表皮生长因子(EGF)、表皮生长因子受体(EGFR)和c-erbB-2(HER-2/neu)基因产物在胃癌、肝癌、乳腺癌、卵巢癌和肺癌中发挥作用。最近的报告表明,它们也参与胰腺导管癌的生长、侵袭和转移。

患者与方法

对36例胰腺导管癌患者进行了性别、年龄、组织学类型、恶性程度(G)、pTN分期(pTN)、局部淋巴结受累情况及远处转移的分析。采用免疫组织化学方法测定肿瘤组织中EGF、EGFR和c-erbB-2的表达水平。

结果

36例患者中,24例c-erbB-2呈阳性表达,13例EGF呈阳性表达,18例EGFR呈阳性表达。EGF和EGFR的过表达与淋巴结及其他器官转移相关。肿瘤组织中EGF表达与EGFR表达之间也存在相关性。未发现c-erbB-2蛋白表达与任何参数相关。

结论

EGF和EGFR在肿瘤通过淋巴结受累及转移至其他器官的过程中起关键作用。

相似文献

1
Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.表皮生长因子(EGF)和表皮生长因子受体(EGFR)的表达与胰腺导管癌的转移密切相关。
Anticancer Res. 2008 Mar-Apr;28(2B):1399-404.
2
Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.表皮生长因子受体在人类胰腺癌中的表达:对肝转移的意义。
Int J Mol Med. 2003 Mar;11(3):305-9.
3
Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.c-erbB-2癌基因蛋白、表皮生长因子受体及转化生长因子-β1在人胰腺导管腺癌中的表达
Hepatobiliary Pancreat Dis Int. 2002 Nov;1(4):620-3.
4
Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.表皮生长因子受体(EGFR)与人类表皮生长因子受体-2(HER-2)在胰腺导管腺癌中的共表达:一项使用免疫组织化学并与荧光原位杂交基因扩增相关联的对比研究。
Oncol Rep. 2007 Jul;18(1):151-5.
5
Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.表皮生长因子和凋亡标志物在胰腺导管腺癌中的表达
Folia Histochem Cytobiol. 2009;47(4):667-71. doi: 10.2478/v10042-010-0008-0.
6
Relationship between c-erbB-2 oncoprotein, epidermal growth factor receptor, and estrogen receptor expression in patients with ductal breast carcinoma. Association with tumor phenotypes.导管乳腺癌患者中c-erbB-2癌蛋白、表皮生长因子受体与雌激素受体表达之间的关系。与肿瘤表型的关联。
In Vivo. 1996 Mar-Apr;10(2):217-22.
7
Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌中c-erbB受体、基质金属蛋白酶和血管内皮生长因子的表达
Oncol Rep. 2004 Aug;12(2):229-37.
8
Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer.表皮生长因子及其受体作为中国胰腺癌患者的预后指标
Anticancer Res. 1998 Nov-Dec;18(6B):4613-9.
9
Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.1型生长因子受体家族不同成员的过表达及其与壶腹周围癌细胞增殖的关系。
J Pathol. 1996 Feb;178(2):140-5. doi: 10.1002/(SICI)1096-9896(199602)178:2<140::AID-PATH450>3.0.CO;2-U.
10
Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.c-erbB-2癌基因与表皮生长因子受体(EGF-R)预后不良产物在乳腺癌和宫颈癌中的分布
Indian J Physiol Pharmacol. 2002 Oct;46(4):423-33.

引用本文的文献

1
In silico screening of chalcone derivatives as promising EGFR-TK inhibitors for the clinical treatment of cancer.计算机模拟筛选查尔酮衍生物作为有前景的表皮生长因子受体酪氨酸激酶(EGFR-TK)抑制剂用于癌症临床治疗。
3 Biotech. 2024 Jan;14(1):18. doi: 10.1007/s13205-023-03858-8. Epub 2023 Dec 19.
2
Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I Investigation.表皮生长因子受体/人表皮生长因子受体2(EGFR/HER2)通路双重靶向联合全身化疗用于难治性胰腺癌的CONKO-008 I期研究
J Clin Med. 2022 Aug 21;11(16):4905. doi: 10.3390/jcm11164905.
3
MASTL regulates EGFR signaling to impact pancreatic cancer progression.
MASTL 通过调控 EGFR 信号通路影响胰腺癌的进展。
Oncogene. 2021 Sep;40(38):5691-5704. doi: 10.1038/s41388-021-01951-x. Epub 2021 Jul 30.
4
Rethink of EGFR in Cancer With Its Kinase Independent Function on Board.基于其激酶非依赖性功能对癌症中表皮生长因子受体(EGFR)的重新思考
Front Oncol. 2019 Aug 23;9:800. doi: 10.3389/fonc.2019.00800. eCollection 2019.
5
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells.表皮生长因子受体抑制剂达可替尼抑制胰腺导管腺癌细胞的增殖和侵袭。
Cell Oncol (Dordr). 2019 Aug;42(4):491-504. doi: 10.1007/s13402-019-00448-w. Epub 2019 Apr 25.
6
The genetic association between EGF A61G polymorphism (rs4444903) and risk of colorectal cancer: An update meta-analysis and trial sequential analysis.表皮生长因子A61G多态性(rs4444903)与结直肠癌风险之间的遗传关联:一项更新的荟萃分析和试验序贯分析
Medicine (Baltimore). 2019 Jan;98(2):e14007. doi: 10.1097/MD.0000000000014007.
7
African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression.患有胰腺导管腺癌的非裔美国人在Kaiso表达上存在性别差异。
Cancer Lett. 2016 Oct 1;380(2):513-522. doi: 10.1016/j.canlet.2016.06.025. Epub 2016 Jul 15.
8
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer.贝伐单抗、厄洛替尼和卡培他滨同步进行巩固性放疗用于不可切除胰腺癌的I期试验
PLoS One. 2016 Jun 23;11(6):e0156910. doi: 10.1371/journal.pone.0156910. eCollection 2016.
9
Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.在胰腺癌模型中,联合靶向转化生长因子-β(TGF-β)、表皮生长因子受体(EGFR)和人表皮生长因子受体2(HER2)可抑制淋巴管生成和转移。
Cancer Lett. 2016 Aug 28;379(1):143-53. doi: 10.1016/j.canlet.2016.05.037. Epub 2016 Jun 3.
10
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma.同时靶向5-脂氧合酶-环氧化酶和表皮生长因子受体可阻断胰腺导管腺癌的进展。
Oncotarget. 2015 Oct 20;6(32):33290-305. doi: 10.18632/oncotarget.5396.